Business Context and Reporting Period
OraSure Technologies, Inc. filed this Form 8-K on March 15, 2005, reporting the entry into a material definitive agreement. The company is incorporated in Delaware and maintains its principal executive offices in Bethlehem, Pennsylvania.
Key Financial Metrics
This filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a contractual amendment.
Material Changes
The company entered into Amendment No. 3 to its Production Agreement with Koninklijke Utermöhlen N.V. (Utermöhlen), originally dated June 8, 1998. Key changes include:
- Extension of the agreement term specifically for Histofreezer® products.
- Establishment of minimum purchase commitments for OraSure.
- Adjustment of the purchase price for the Freeze Off™ product.
- Implementation of price adjustment mechanisms for Histofreezer® products based on Euro/U.S. Dollar exchange rate fluctuations.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of general business risks. The primary contingency noted is the financial exposure to currency exchange rate fluctuations affecting the purchase price of Histofreezer® products.
Investor Verification Points
- Verify the specific minimum purchase commitment volumes established in the amendment.
- Confirm the exact pricing adjustment formula for Freeze Off™ and Histofreezer® products.
- Assess the impact of the extended term and currency clauses on future cost of goods sold.